Novo Nordisk A/S shareholders who purchased their securities between May 7, 2025, and July 28, 2025, are advised by Rosen Law Firm to consider legal action. With the lead plaintiff deadline set for September 30, 2025, investors are encouraged to act promptly to secure potential compensation.

Investors in Venture Global, Inc. have until April 18 to seek the role of lead plaintiff in a federal securities class action filed against the company. Leading law firm Faruqi & Faruqi, LLP is investigating potential claims on behalf of those who suffered significant losses.